Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Yan, Caifeng ^a   Chen, Jinfeng ^b   Chen, Nuoqi ^b  

^a CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; MALAT1 LONG NON-CODING RNA, HUMAN; MALAT1 LONG NON-CODING RNA, MOUSE; SREBF1 PROTEIN, HUMAN; SREBF1 PROTEIN, MOUSE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ANIMAL; CELL NUCLEUS; FATTY LIVER; GENETICS; HEP-G2 CELL LINE; HUMAN; LIPID METABOLISM; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PROTEIN STABILITY;

ANIMALS; CELL NUCLEUS; FATTY LIVER; HEP G2 CELLS; HUMANS; LIPID METABOLISM; MICE; MICE, OBESE; PROTEIN STABILITY; RNA, LONG NONCODING; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84960101919     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22640     Document Type: Article

References (31)

1. Maruthur, N. M. The growing prevalence of type 2 diabetes: increased incidence or improved survival? Curr Diab Rep 13, 786-94 (2013).
2. Tangvarasittichai, S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes 6, 456-80 (2015).
3. Zhang, Y. et al. Positive correlations of liver enzymes with metabolic syndrome including insulin resistancein newly diagnosed type 2 diabetes mellitus. Endocrine 38, 181-7 (2010).
4. Park, M. H. & Han, J. S. Padina arborescens Ameliorates Hyperglycemia and Dyslipidemia in C57BL/KsJ-db/db Mice, a Model of Type 2 Diabetes Mellitus. J Med Food 18, 1088-94 (2015).
5. Krssak, M. & Roden, M. The role of lipid accumulation in liver and muscle for insulin resistance and type 2 diabetes mellitus in humans. Rev Endocr Metab Disord 5, 127-34 (2004).
6. Knebel, B. et al. Phosphorylation of sterol regulatory element-binding protein (SREBP)-1c by p38 kinases, ERK and JNK influences lipid metabolism and the secretome of human liver cell line HepG2. Arch Physiol Biochem 120, 216-27 (2014).
7. Kotzka, J. et al. Identification of a gene variant in the master regulator of lipid metabolism SREBP-1 in a family with a novel form of severe combined hypolipidemia. Atherosclerosis 218, 134-43 (2011).
8. Nakamuta, M. et al. Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease. Int J Mol Med 23, 603-8 (2009).
9. Kammoun, H. L. et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest 119, 1201-15 (2009).
10. Shimano, H. et al. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem 274, 35832-9 (1999).
11. Becard, D. et al. Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice. Diabetes 50, 2425-30 (2001).
12. Yahagi, N. et al. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol Chem 277, 19353-7 (2002).
13. Dossi, C. G. et al. Reversal of high-fat diet-induced hepatic steatosis by n-3 LCPUFA: role of PPAR-α and SREBP-1c. J Nutr Biochem 25, 977-84 (2014).
14. Zhao, X. Y. & Lin, J. D. Long Noncoding RNAs: A New Regulatory Code in Metabolic Control. Trends Biochem Sci 40, 586-96 (2015).
15. Wei, Y. & Niu, B. Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A SystematicReview of the Literature with Meta-Analysis. Dis Markers 2015, 164635 (2015).
16. Yan, B. et al. Aberrant expression of long noncoding RNAs in early diabetic retinopathy. Invest Ophthalmol Vis Sci 55, 941-51 (2014).
17. Liu, J. Y. et al. Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis 5, e1506 (2014).
18. Puthanveetil, P. et al. Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells. J Cell Mol Med 19, 1418-25 (2015).
19. Watts, R. et al. Myostatin inhibits proliferation and insulin-stimulated glucose uptake in mouse liver cells. Biochem Cell Biol 92, 226-34 (2014).
20. Huarte, M. et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in thep53 response. Cell 142, 409-19 (2010).
21. Biddinger, S. B. et al. Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome. Diabetes 54, 1314-23 (2005).
22. Gruben, N., Shiri-Sverdlov, R., Koonen, D. P. & Hofker, M. H. Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison? Biochim Biophys Acta 1842, 2329-43 (2014).
23. Guttman, M. et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477, 295-300 (2011).
24. Miyagawa, R. et al. Identification of cis-and trans-acting factors involved in the localization of MALAT-1 noncoding RNA to nuclear speckles. RNA 18, 738-51 (2012).
25. Lee, M. et al. Salicortin-derivatives from Salix pseudo-lasiogyne twigs inhibit adipogenesis in 3T3-L1 cells via modulation of C/EBPα and SREBP1c dependent pathway. Molecules 18, 10484-96 (2013).
26. Pettinelli, P. et al. Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion Biochim Biophys Acta 1792, 1080-6 (2009).
27. Frederico, M. J. et al. Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fattyliver disease in mice. Scand J Gastroenterol 46, 1381-8 (2011).
28. Li, H. et al. AMPK activation prevents excess nutrient-induced hepatic lipid accumulation by inhibiting mTORC1 signaling and endoplasmic reticulum stress response. Biochim Biophys Acta 1842, 1844-54 (2014).
29. Edwards, M., Houseman, L., Phillips, I. R. & Shephard, E. A. Isolation of mouse hepatocytes. Methods Mol Biol 987, 283-93 (2013).
30. Moon, Y. A. et al. The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. Cell Metab 15, 240-6 (2012).
31. Xu, C. et al. MALAT-1: a long non-coding RNA and its important 3′ end functional motif in colorectalcancer metastasis. Int J Oncol 39, 169-75 (2011).